Get the Stockscreener App
326.86
0.03%
-0.1636
Penumbra Inc stock is traded at $326.86, with a volume of 80,247.
It is down -0.03% in the last 24 hours and up +2.71% over the past month.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.
See More
Previous Close:
$327.02
Open:
$326.36
24h Volume:
80,247
Relative Volume:
0.21
Market Cap:
$12.88B
Revenue:
$1.45B
Net Income/Loss:
$171.05M
P/E Ratio:
75.21
EPS:
4.3459
Net Cash Flow:
$212.73M
1W Performance:
+0.29%
1M Performance:
+2.71%
6M Performance:
-4.13%
1Y Performance:
+29.21%
1-Day Range:
$326.36
$327.61
1-Week Range:
$325.25
$328.11
52-Week Range:
$221.26
$362.41
Penumbra Inc Stock (PEN) Company Profile
Name
Penumbra Inc
Sector
Industry
Phone
(510) 995-2486
Address
ONE PENUMBRA PLACE, ALAMEDA, CA
Compare PEN vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PEN
Penumbra Inc
|
326.88 | 12.88B | 1.45B | 171.05M | 212.73M | 4.3459 |
ABT
Abbott Laboratories
|
110.11 | 192.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
332.33 | 130.11B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
90.67 | 116.83B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
51.55 | 75.11B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.83 | 52.80B | 6.30B | 1.07B | 1.09B | 1.8406 |
Penumbra Inc Stock (PEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-18-25 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-11-25 | Upgrade | Citigroup | Neutral → Buy |
| Nov-18-25 | Initiated | Wells Fargo | Underweight |
| Oct-08-25 | Upgrade | Needham | Hold → Buy |
| Sep-02-25 | Initiated | Evercore ISI | Outperform |
| Mar-14-25 | Initiated | BofA Securities | Buy |
| Jan-21-25 | Initiated | UBS | Buy |
| Dec-17-24 | Initiated | Oppenheimer | Outperform |
| Dec-11-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Sep-18-24 | Initiated | Stifel | Buy |
| Sep-03-24 | Initiated | Leerink Partners | Outperform |
| Jul-31-24 | Downgrade | Citigroup | Buy → Neutral |
| Jul-31-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-23-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-06-23 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Mar-29-23 | Downgrade | Needham | Buy → Hold |
| Jan-30-23 | Initiated | Piper Sandler | Overweight |
| Nov-04-22 | Upgrade | Citigroup | Neutral → Buy |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Oct-05-22 | Downgrade | Citigroup | Buy → Neutral |
| Sep-09-22 | Upgrade | Needham | Hold → Buy |
| Jul-18-22 | Initiated | RBC Capital Mkts | Outperform |
| Apr-19-22 | Initiated | Deutsche Bank | Buy |
| Mar-08-22 | Initiated | Needham | Hold |
| Sep-16-21 | Initiated | Truist | Buy |
| Jun-04-21 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-16-20 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-07-20 | Resumed | Canaccord Genuity | Buy |
| Sep-29-20 | Initiated | BTIG Research | Buy |
| Sep-08-20 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Jun-13-19 | Reiterated | BofA/Merrill | Buy |
| May-30-19 | Upgrade | JP Morgan | Neutral → Overweight |
| May-21-19 | Initiated | William Blair | Outperform |
| Oct-29-18 | Resumed | BofA/Merrill | Buy |
| Oct-08-18 | Initiated | RBC Capital Mkts | Outperform |
| Feb-21-18 | Initiated | William Blair | Outperform |
| Jan-02-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-30-15 | Reiterated | Canaccord Genuity | Buy |
| Oct-13-15 | Initiated | Wells Fargo | Outperform |
View All
Penumbra Inc Stock (PEN) Latest News
Alberta Investment Management Corp Invests $10.46 Million in Penumbra, Inc. $PEN - MarketBeat
S&CO Inc. Takes Position in Penumbra, Inc. $PEN - MarketBeat
Technical Reactions to PEN Trends in Macro Strategies - Stock Traders Daily
Penumbra, Inc.: Financial Data Forecasts Estimates and Expectations | PEN | US70975L1070 - marketscreener.com
Barclays PLC (PEN) discloses 2.34M-share beneficial stake in Penumbra Inc - Stock Titan
Should Penumbra’s RED 68 Catheter Recall and Margin Strain Require Action From Penumbra (PEN) Investors? - webull.com
Penumbra, Inc. (PEN) stock price, news, quote and history - Yahoo Finance Singapore
Penumbra, Inc. (PEN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Washington Trust Advisors, Inc.'s Penumbra Inc(PEN) Holding History - GuruFocus
THUNDER Study Demonstrates Penumbra's THUNDERBOLT is Safe and Effective for Stroke Care - Nonstop Local News Montana
Penumbra, Inc. (PEN) Stock Analysis: Evaluating the 11.45% Potential Upside in Medical Devices - directorstalkinterviews.com
Penumbra Inc (PEN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Bank of America Corp DE Sells 46,436 Shares of Penumbra, Inc. $PEN - MarketBeat
Royal Bank of Canada Decreases Holdings in Penumbra, Inc. $PEN - MarketBeat
Penumbra Inc (PEN) Stock News Today - TradingKey
The Manufacturers Life Insurance Company Sells 65,658 Shares of Penumbra, Inc. $PEN - MarketBeat
THUNDER study demonstrates Penumbra's Thunderbolt CAVT system is safe and effective for stroke care - Med-Tech Insights
Penumbra, Inc. (PEN) Stock Forecasts - finance.yahoo.com
Did Penumbra's (PEN) Voluntary RED 68 Catheter Recall Just Shift Its Investment Narrative? - simplywall.st
California State Teachers Retirement System Purchases 7,800 Shares of Penumbra, Inc. $PEN - MarketBeat
Sei Investments Co. Trims Stock Holdings in Penumbra, Inc. $PEN - MarketBeat
Amundi Buys 259,936 Shares of Penumbra, Inc. $PEN - MarketBeat
Penumbra Stock Price Forecast. Should You Buy PEN? - StockInvest.us
Penumbra (NYSE:PEN) Posts Earnings Results, Misses Expectations By $0.27 EPS - MarketBeat
Penumbra Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Penumbra: Q2 Earnings Snapshot - marketscreener.com
Penumbra, Inc. Reports Second Quarter 2026 Financial Results - Barchart.com
Penumbra Q2 revenue rises 14.9% amid Boston Sci... - Pluang
Penumbra, Inc. Revenue Breakdown – NYSE:PEN - TradingView
85,000 Shares in Penumbra, Inc. $PEN Purchased by Empyrean Capital Partners LP - MarketBeat
Penumbra Releases Results of CAVT System Study for Stroke Patients - dicardiology.com
Penumbra Inc (PEN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Penumbra Inc (PEN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Penumbra Inc (PEN) Income Statement - TradingKey
Penumbra Inc (PEN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Penumbra Inc (PEN) Cash Flow - TradingKey
Penumbra Inc (PEN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Penumbra Inc (PEN) Institutional Confidence - TradingKey
PEN|Penumbra Inc|Price:318.730|Chg%:+0.760 - TradingKey
Sculptor Capital LP Invests $18.72 Million in Penumbra, Inc. $PEN - MarketBeat
Penumbra Market Sentiment - Benzinga España
WHITEBOX ADVISORS LLC's Penumbra Inc(PEN) Holding History - GuruFocus
Penumbra, Inc. (NYSE:PEN) Receives Average Rating of "Hold" from Analysts - MarketBeat
Penumbra (PEN) Following THUNDERBOLT Debut, Is The Stock A Bargain Or Fairly Valued - Yahoo Finance
Penumbra (PEN) Wins FDA Clearance For THUNDERBOLT After Strong Stroke Study - Yahoo Finance
Penumbra, Inc. Revenue Breakdown – BMV:PEN - TradingView
Magnendo Corp. announced that it has received $18 million in funding from Penumbra, Inc. and other investors - marketscreener.com
Magnendo Secures $18M Series A Financing to Transform Endovascular Access for Stroke Intervention - The Manila Times
Penumbra stock reflects growth ambitions amid recent revenue gains - Ad-hoc-news.de
SA JPMorgan Mid-Cap Growth Portfolio's Penumbra Inc(PEN) Holding History - GuruFocus
DLD Asset Management LP Makes New Investment in Penumbra, Inc. $PEN - marketbeat.com
Penumbra Inc Stock (PEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):